Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1101/cshperspect.a014092 http://scihub22266oqcxt.onion/10.1101/cshperspect.a014092 C4031952!4031952!24890831     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cold+Spring+Harb+Perspect+Med 2014 ; 4 (6): ä Nephropedia Template TP {{tp|p=24890831|t=2014. Cardiovascular Drug Discovery: A Perspective from a Research-Based Pharmaceutical Company |pdf=|usr=}}{{24890831}} gab.com Text Cardiovascular Drug Discovery: A Perspective from a Research-Based Pharmaceutical Company JO: Cold Spring Harb Perspect Med http://www.kidney.de/pget.php?&tw=1&pmid=24890831 #FOAvip The theme of this review is to summarize the evolving processes in cardiovascular drug discovery and development within a large pharmaceutical company. Emphasis is placed on the contrast between the academic and industrial research operating environments, which can influence the effectiveness of research collaboration between the two constituencies, but which plays such an important role in drug innovation. The strategic challenges that research directors face are also emphasized. The need for improved therapy in many cardiovascular indications remains high, but the feasibility in making progress, despite the advances in molecular biology and genomics, is also assessed. Twit Text FOAVip Cardiovascular Drug Discovery: A Perspective from a Research-Based Pharmaceutical Company ????Cold Spring Harb Perspect Med http://www.kidney.de/pget.php?&tw=1&pmid=24890831 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24890831 #FOAvip English Wikipedia <ref>{{Cite pmid|24890831}}</ref> Cardiovascular Drug Discovery: A Perspective from a Research-Based Pharmaceutical Company #MMPMID24890831 Gromo G; Mann J; Fitzgerald J Cold Spring Harb Perspect Med 2014[Jun]; 4 (6): ä PMID24890831show ga The theme of this review is to summarize the evolving processes in cardiovascular drug discovery and development within a large pharmaceutical company. Emphasis is placed on the contrast between the academic and industrial research operating environments, which can influence the effectiveness of research collaboration between the two constituencies, but which plays such an important role in drug innovation. The strategic challenges that research directors face are also emphasized. The need for improved therapy in many cardiovascular indications remains high, but the feasibility in making progress, despite the advances in molecular biology and genomics, is also assessed. äCardiovascular Drug Discovery: A Perspective from a Research-Based Pha(epmc).pdf DeepDyve Pubget Overpricing